Benchmark
Launches
Andrew Pannu@andrewpannu

We're launching Sleuth today. The intelligence platform for biopharma's highest-stakes decisions, in use at top companies in the world. To celebrate, we broke down the Chinese landscape: 18K+ assets & a map of the strategic white space. RT + comment "Sleuth" for access. t.co/QOx48Pc95D

We're launching Sleuth today.
Views
451,457
Likes
259
Replies
166
Reposts
62
Quotes
8
Bookmarks
174
Xvideo

We're launching Sleuth today.

Sleuth is introduced as an intelligence platform for high-stakes biopharma decisions. It maps drug programs, mechanisms, competitors, clinical data, deals, and internal data, with a launch focus on the Chinese biopharma pipeline and strategic opportunities through 2026.

Views
451.5K
Likes
259
Replies
166
Reposts
62
Quotes
8
Bookmarks
174
Topics

Analysis

Sleuth is introduced as an intelligence platform for high-stakes biopharma decisions. It maps drug programs, mechanisms, competitors, clinical data, deals, and internal data, with a launch focus on the Chinese biopharma pipeline and strategic opportunities through 2026.

Formats
Product announcementFounder pitchCall to action
Topics
Biopharma IntelligenceDrug Pipeline AnalysisStrategic Deal MappingChinese Biopharma Landscape
Categories
BiotechnologyBusiness StrategyData Intelligence

Sign in to see the full analysis.

Sign in

Visual hook

How the visuals workThe visuals support the spoken pitch: a founder speaks directly to camera while captions emphasize key claims. Branding and investor logos appear near the end, reinforcing the product launch and credibility message.
As written
We're launching Sleuth today.
From the post
  1. 01
    The Announcement

    Open with a direct announcement that a new product, project, or offering is now available.

  2. 02
    The Positioning

    Explain what the offering is for and add credibility by showing who uses it or why it matters.

  3. 03
    The Access CTA

    Share a useful launch asset, add a concrete proof point, and tell readers how to request access.